Inventor
CAMPBELL MICHAEL G
US12 patents
⚠️ This page may combine multiple inventors who share the name “CAMPBELL MICHAEL G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVANIR PHARMACEUTICALS
5 patentsUS6919366B2Jul 19, 2005
Benzimidazole derivatives as modulators of IgE
AVANIR PHARMACEUTICALS43 citations92
US6369091B1Apr 9, 2002
Benzimidazole analogs as down-regulators of IgE
AVANIR PHARMACEUTICALS51 citations92
US6303645B1Oct 16, 2001
Benzimidazole derivatives as modulators of IgE
AVANIR PHARMACEUTICALS21 citations92
US6271390B1Aug 7, 2001
Suppression of the IgE-dependent allergic response by benzimidazole analogs
AVANIR PHARMACEUTICALS22 citations92
US6911462B2Jun 28, 2005
Benzimidazole compounds for regulating IgE
AVANIR PHARMACEUTICALS13 citations83
ATHERSYS INC
5 patentsUS7981896B2Jul 19, 2011
Pyrazoles for the treatment of obesity and other CNS disorders
ATHERSYS INC10 citations80
US7855224B2Dec 21, 2010
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders
ATHERSYS INC0 citations48
US7528262B2May 5, 2009
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders
ATHERSYS INC0 citations48
US7897634B2Mar 1, 2011
Pyrazoles for the treatment of obesity and other CNS disorders
ATHERSYS INC0 citations46
US7319103B2Jan 15, 2008
Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders
ATHERSYS INC0 citations40